CEBPA and acute myeloid leukemia: We further confirmed that IL‐1β mRNA expression was significantly lower in the bone marrow (BM) cells of C/EBPα DM AML patients than WT (Figure 5F), while the CD8+CD69+ T cell proportion was specifically elevated in BM rather than peripheral blood (PB).